Year :
2020
| Month :
November
| Volume :
14
| Issue :
11
| Page :
DR01 - DR04
Full Version
Myroides causing Catheter Associated
Urinary Tract Infection in Diabetic
Patients: An Emerging Multidrug
Resistant "Superbug"
Published: November 1, 2020 | DOI: https://doi.org/10.7860/JCDR/2020/46584.14322
Kalpana Chauhan, Priyanka Chaturvedi, Ravi Pratap Singh, Anita Pandey
1. Associate Professor, Department of Microbiology, Subharti Medical College, Meerut, Uttar Pradesh, India.
2. Tutor, Department of Microbiology, Subharti Medical College, Meerut, Uttar Pradesh, India.
3. Assistant Medical Superintendent, Department of Biochemistry, Subharti Medical College, Meerut, Uttar Pradesh, India.
4. Professor and Head, Department of Microbiology, Subharti Medical College, Meerut, Uttar Pradesh, India.
Correspondence Address :
Kalpana Chauhan,
Department of Microbiology, Subharti Medical College, Meerut, Uttar Pradesh, India.
E-mail: drkalpanamicro@gmail.com
Abstract
Myroidesis a nonfermentative, gram-negative rod shaped bacterium which is an emerging multidrug resistant pathogen causing many serious hospital acquired infections like Catheter Associated Urinary Tract Infection (CAUTI). The authors report a case series (four cases) of CAUTI caused by Myroides species which was resistant to all tested antibiotics (ticarcillin-clavulanic acid, piperacillin-tazobactam, ceftazidime, cefepime, aztreonam, cefoperazonesulbactam, imipenem, meropenem, amikacin, gentamycin ciprofloxacin, levofloxacin, colistin, tigecycline) and sensitive only to minocycline (minimum inhibitory concentration <1 µg/mL), in long-standing Diabetic Mellitus Type II patients. All the four patients were successfully treated with minocycline. Present cases highlight the importance of Myroides as a pathogen in Urinary Tract Infection (UTI) in diabetic patients, especially in nosocomial settings which clinicians should keep in mind.
Keywords
Immunocompromised, Myroidesis, Urinary tract infection
DOI: 10.7860/JCDR/2020/46584.14322
Date of Submission: Sep 02, 2020
Date of Peer Review: Sep 26, 2020
Date of Acceptance: Oct 19, 2020
Date of Publishing: Nov 01, 2020
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Sep 04, 2020
• Manual Googling: Oct 17, 2020
• iThenticate Software: Oct 27, 2020 (23%)
ETYMOLOGY: Author Origin
|